Aragam, K.G.* ; Jiang, T.* ; Goel, A.* ; Kanoni, S.* ; Wolford, B.N.* ; Atri, D.S.* ; Weeks, E.M.* ; Wang, M.* ; Hindy, G.* ; Zhou, W.* ; Grace, C.* ; Roselli, C.* ; Marston, N.A.* ; Kamanu, F.K.* ; Surakka, I.* ; Venegas, L.M.* ; Sherliker, P.* ; Koyama, S.* ; Ishigaki, K.* ; Asvold, B.O.* ; Brown, M.R.* ; Brumpton, B.M.* ; de Vries, P.S.* ; Giannakopoulou, O.* ; Giardoglou, P.* ; Gudbjartsson, D.F.* ; Güldener, U.* ; Haider, S.M.I.* ; Helgadottir, A.* ; Ibrahim, M.* ; Kastrati, A.* ; Kessler, T.* ; Kyriakou, T.* ; Konopka, T.* ; Li, L.* ; Ma, L.* ; Meitinger, T. ; Mucha, S.* ; Münz, M.* ; Murgia, F.* ; Nielsen, J.B.* ; Nöthen, M.M.* ; Pang, S.* ; Reinberger, T.* ; Schnitzler, G.* ; Smedley, D.* ; Thorleifsson, G.* ; von Scheidt, M.* ; Ulirsch, J.C.* ; Danesh, J.* ; Arnar, D.O.* ; Burtt, N.P.* ; Costanzo, M.C.* ; Flannick, J.* ; Ito, K.* ; Jang, D.K.* ; Kamatani, Y.* ; Khera, A.V.* ; Komuro, I.* ; Kullo, I.J.* ; Lotta, L.A.* ; Nelson, C.P.* ; Roberts, R.* ; Thorgeirsson, G.* ; Thorsteinsdottir, U.* ; Webb, T.R.* ; Baras, A.* ; Bjorkegren, J.L.M.* ; Boerwinkle, E.* ; Dedoussis, G.* ; Holm, H.* ; Hveem, K.* ; Melander, O.* ; Morrison, A.C.* ; Orho-Melander, M.* ; Rallidis, L.S.* ; Ruusalepp, A.* ; Sabatine, M.S.* ; Stefansson, K.* ; Zalloua, P.A.* ; Ellinor, P.T.* ; Farrall, M.* ; Ruff, C.T.* ; Finucane, H.K.* ; Hopewell, J.C.* ; Clarke, R.* ; Gupta, R.M.* ; Erdmann, J.* ; Samani, N.J.* ; Schunkert, H.* ; Watkins, H.* ; Willer, C.J.* ; Deloukas, P.* ; Kathiresan, S.* ; Butterworth, A.S.*
     
 
    
        
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.
    
    
        
    
    
        
        Nat. Genet. 54, 1803-1815 (2022)
    
    
    
		
		
			
				The discovery of genetic loci associated with complex diseases has outpaced the elucidation of mechanisms of disease pathogenesis. Here we conducted a genome-wide association study (GWAS) for coronary artery disease (CAD) comprising 181,522 cases among 1,165,690 participants of predominantly European ancestry. We detected 241 associations, including 30 new loci. Cross-ancestry meta-analysis with a Japanese GWAS yielded 38 additional new loci. We prioritized likely causal variants using functionally informed fine-mapping, yielding 42 associations with less than five variants in the 95% credible set. Similarity-based clustering suggested roles for early developmental processes, cell cycle signaling and vascular cell migration and proliferation in the pathogenesis of CAD. We prioritized 220 candidate causal genes, combining eight complementary approaches, including 123 supported by three or more approaches. Using CRISPR–Cas9, we experimentally validated the effect of an enhancer in MYO9B, which appears to mediate CAD risk by regulating vascular cell motility. Our analysis identifies and systematically characterizes >250 risk loci for CAD to inform experimental interrogation of putative causal mechanisms for CAD.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Genome-wide Association; Loci; Inhibition; Identification; Metaanalysis; Design
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2022
    
 
    
        Prepublished im Jahr 
        0
    
 
    
        HGF-Berichtsjahr
        2022
    
 
    
    
        ISSN (print) / ISBN
        1061-4036
    
 
    
        e-ISSN
        1546-1718
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 54,  
	    Heft: 12,  
	    Seiten: 1803-1815 
	    Artikelnummer: ,  
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            Nature Publishing Group
        
 
        
            Verlagsort
            New York, NY
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
    
 
    
        Forschungsfeld(er)
        Genetics and Epidemiology
    
 
    
        PSP-Element(e)
        G-500700-001
    
 
    
        Förderungen
        National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services
National Human Genome Research Institute
National Institutes of Health
NIH Roadmap for Medical Research
Stiftelsen Kristian Gerhard Jebsen
Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology
Corona-Foundation (Junior Research Group Translational Cardiovascular Genomics)
Bavarian State Ministry of Health and Care
German Federal Ministry of Education and Research (BMBF)
British Heart Foundation (BHF)/German Centre of Cardiovascular Research (DZHK)
Sonderforschungsbereich
UK National Institute for Health Research (NIHR)
University of Michigan Medical School
Central Norway Regional Health Authority
German Research Foundation (DFG)
Medical Research Council DTP studentship
British Heart Foundation
Oxford BHF Centre of Research Excellence
British Heart Foundation Centre of Research Excellence
British Heart Foundation (BHF)
American Heart Association
National Heart, Lung, and Blood Institute
AMED
Swedish Research Council
Heart Lung Foundation
Foundation Leducq (PlaqueOmics: New Roles of Smooth Muscle and Other Matrix Producing Cells in Atherosclerotic Plaque Stability and Rupture)
American Heart Association Institute for Precision Cardiovascular Medicine
Harvard Catalyst
National Health and Medical Research Council (NHMRC) of Australia
National Institute of Diabetes and Digestive and Kidney Diseases
UK Medical Research Council
European Commission
NIHR Cambridge Biomedical Research Centre
Health Data Research UK - UK Medical Research Council
Engineering and Physical Sciences Research Council
Economic and Social Research Council
Department of Health and Social Care (England)
Chief Scientist Office of the Scottish Government Health and Social Care Directorates
Health and Social Care Research and Development Division (Welsh Government)
Public Health Agency (Northern Ireland)
Wellcome
TriPartite Immunometabolism Consortium (TrIC)-NovoNordisk Foundation
VIAgenomics
Wellcome Trust core award
NIHR Oxford Biomedical Research Centre
NIH
Japan Agency for Medical Research and Development, AMED
BHF
Swedish Heart and Lung Foundation
European Research Council
Lund University Infrastructure grant 'Malmo population-based cohorts'
National Science Foundation Graduate Research Program (DGE)
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2022-12-15